Flow Cytometry Revenue and Competitors

At Intellicyt, our mission is to enable bioscience enterprises to rapidly and cost effectively screen and profile disease- and physiologically-relevant model systems for phenotypic endpoints using cell-based and/or bead-based assays. We do this by providing easy-to-use hardware, software, and reagent systems that are optimized to conserve precious samples, use less reagent, and to minimize time-to-answer to both enhance workflow productivity and to preserve the biology of interest. All major pharmaceutical companies and many biotechnology companies and academic institutions have invested in Intellicyt solutions to give their cell-based screening campaigns the edge.